ENOV vs AORT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

ENOV

29.5
AI Score
VS
AORT Wins

AORT

38.7
AI Score

Investment Advisor Scores

ENOV

30score
Recommendation
AVOID NEW MONEY

AORT

39score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric ENOV AORT Winner
Forward P/E 6.9109 30.3951 ENOV
PEG Ratio 1.8989 181.5 ENOV
Revenue Growth 1.8% 9.2% AORT
Earnings Growth 153.1% 0.0% ENOV
Tradestie Score 29.5/100 38.7/100 AORT
Profit Margin -22.9% -3.6% AORT
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

ENOV 1M: +54.6% · 3M: +14.3% AORT 1M: -6.1% · 3M: -28.5%

Current Technical Phase

ENOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 70

RSI (14): 70.2 · Price: $28.22

AORT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.5%), weak momentum, RSI 40

RSI (14): 39.5 · Price: $20.47

Fundamentals Snapshot

Metric ENOV AORT
Market Cap — —
Forward P/E 8.1 39.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.6% 0.6%
Operating Margin 0.0% 0.0%
EPS -9.23 -0.36
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, AORT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.